fluorodeoxyglucose f18 has been researched along with Immunoblastic Large-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananthasivan, R; Chandra, S; Kavindran, R; Seshadri, N; Srikanth, G | 1 |
| Fujiwara-Yamada, M; Ichinohasama, R; Inomata, M; Ito, T; Meguro, K; Yokoyama, H | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Immunoblastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Abscess; Liver Neoplasms; Lymphoma, Large-Cell, Immunoblastic; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2010 |
Immunoglobulin G4-positive plasmablastic lymphoma.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunophenotyping; Lymphoma, Large-Cell, Immunoblastic; Multimodal Imaging; Neoplasms, Plasma Cell; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |